Zydus Lifesciences announced the re-appointment of Dr. Sharvil P. Patel as Managing Director for a five-year term effective April 1, 2027, to March 31, 2032. Additionally, Mr. Kulin S. Lalbhai has been appointed as an Independent Director for a five-year term from May 19, 2026, to May 18, 2031. These appointments were approved by shareholders at the company’s Thirty First Annual General Meeting.
Leadership Appointments at Zydus Lifesciences
Zydus Lifesciences has confirmed key leadership changes following its Thirty First Annual General Meeting. Shareholders have approved the re-appointment of Dr. Sharvil P. Patel as the Managing Director. His new term will commence on April 1, 2027, and extend for five years, concluding on March 31, 2032. This decision ensures leadership continuity in a critical executive role.
New Independent Director Joins Board
In parallel, the company announced the appointment of Mr. Kulin S. Lalbhai as an Independent Director. His tenure on the board will also span five years, starting from May 19, 2026, and concluding on May 18, 2031. These resolutions were passed as ordinary and special resolutions, reflecting the shareholders’ confidence in the company’s governance and strategic direction.
Source: BSE
